DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Primidolol

Primidolol

  • (12) United States Patent (10) Patent No.: US 9,498,481 B2 Rao Et Al

    (12) United States Patent (10) Patent No.: US 9,498,481 B2 Rao Et Al

  • Customs Tariff - Schedule

    Customs Tariff - Schedule

  • Ovid MEDLINE(R)

    Ovid MEDLINE(R)

  • Certain Pharmaceuticals and Intermediate Chemicals: Identification of Applicable 6-Digit HS Subheadings for Products Covered By

    Certain Pharmaceuticals and Intermediate Chemicals: Identification of Applicable 6-Digit HS Subheadings for Products Covered By

  • (12) Patent Application Publication (10) Pub. No.: US 2007/0155676 A1 Burnett Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2007/0155676 A1 Burnett Et Al

  • Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews

    Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews

  • Self-Measured Compared to Office

    Self-Measured Compared to Office

  • The Organic Chemistry of Drug Synthesis

    The Organic Chemistry of Drug Synthesis

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • A Study on Beta Blockers - a Brief Review Tv

    A Study on Beta Blockers - a Brief Review Tv

  • Drugs Acting on the Adrenergic Nervous System (Iv)

    Drugs Acting on the Adrenergic Nervous System (Iv)

  • (11) Application No. AU 2006302237 C1 (19) AUSTRALIAN PATENT OFFICE

    (11) Application No. AU 2006302237 C1 (19) AUSTRALIAN PATENT OFFICE

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

  • Combinations of Sterol Absorption Inhibitor(S) with Cardiovascular Agent(S) for the Treatment of Vascular Conditions

    Combinations of Sterol Absorption Inhibitor(S) with Cardiovascular Agent(S) for the Treatment of Vascular Conditions

  • Pharmacotherapy for Mild Hypertension (Review) – the Cochrane Collaboration

    Pharmacotherapy for Mild Hypertension (Review) – the Cochrane Collaboration

  • Ep 2459564 B1

    Ep 2459564 B1

  • United States Patent (10) Patent N0.: US 6,951,860 B2 Mehanna Et A1

    United States Patent (10) Patent N0.: US 6,951,860 B2 Mehanna Et A1

  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

    Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

Top View
  • Marrakesh Agreement Establishing the World Trade Organization
  • Pharmacophores of the Dual Acting α, β-Blockers As Deduced, from Molecular Dynamics Simulations
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • Beta-Blockers and Inhibitors of the Renin-Angiotensin Aldosterone System for Chronic Heart Failure with Preserved Ejection Fraction (Review)
  • (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
  • Customs Tariff - Schedule Xxi - 1
  • (12) United States Patent (10) Patent No.: US 9,526,824 B2 Ferrari Et Al
  • Wo 2007/044693 A2
  • First-Line Combination Therapy Versus First-Line Monotherapy for Primary Hypertension (Review)
  • Harmonized Tariff Schedule of the United States (2006) Annotated for Statistical Reporting Purposes
  • Harmonized Tariff Schedule of the United States (2006) (Rev
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • (12) Patent Application Publication (10) Pub. No.: US 2003/0069221A1 Kosoglou Et Al
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • An Application to Include Blood Pressure Lowering Drug Fixed Dose
  • Ligand P-Gp Inhibition
  • Beta-Blockers and Inhibitors of the Renin-Angiotensin Aldosterone System for Chronic Heart Failure with Preserved Ejection Fraction (Review)
  • 1111111111111111111Imnumu


© 2024 Docslib.org    Feedback